Cargando…
Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654848/ https://www.ncbi.nlm.nih.gov/pubmed/33173161 http://dx.doi.org/10.1038/s41375-020-01087-z |
| _version_ | 1783608130730459136 |
|---|---|
| author | D’Alessio, A. Del Poggio, P. Bracchi, F. Cesana, G. Sertori, N. Di Mauro, D. Fargnoli, A. Motta, M. Giussani, C. Moro, P. Vitale, G. Giacomini, M. Borra, G. |
| author_facet | D’Alessio, A. Del Poggio, P. Bracchi, F. Cesana, G. Sertori, N. Di Mauro, D. Fargnoli, A. Motta, M. Giussani, C. Moro, P. Vitale, G. Giacomini, M. Borra, G. |
| author_sort | D’Alessio, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7654848 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76548482020-11-12 Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia D’Alessio, A. Del Poggio, P. Bracchi, F. Cesana, G. Sertori, N. Di Mauro, D. Fargnoli, A. Motta, M. Giussani, C. Moro, P. Vitale, G. Giacomini, M. Borra, G. Leukemia Letter Nature Publishing Group UK 2020-11-10 2021 /pmc/articles/PMC7654848/ /pubmed/33173161 http://dx.doi.org/10.1038/s41375-020-01087-z Text en © Springer Nature Limited 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter D’Alessio, A. Del Poggio, P. Bracchi, F. Cesana, G. Sertori, N. Di Mauro, D. Fargnoli, A. Motta, M. Giussani, C. Moro, P. Vitale, G. Giacomini, M. Borra, G. Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
| title | Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
| title_full | Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
| title_fullStr | Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
| title_full_unstemmed | Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
| title_short | Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia |
| title_sort | low-dose ruxolitinib plus steroid in severe sars-cov-2 pneumonia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654848/ https://www.ncbi.nlm.nih.gov/pubmed/33173161 http://dx.doi.org/10.1038/s41375-020-01087-z |
| work_keys_str_mv | AT dalessioa lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT delpoggiop lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT bracchif lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT cesanag lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT sertorin lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT dimaurod lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT fargnolia lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT mottam lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT giussanic lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT morop lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT vitaleg lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT giacominim lowdoseruxolitinibplussteroidinseveresarscov2pneumonia AT borrag lowdoseruxolitinibplussteroidinseveresarscov2pneumonia |